5 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Pneumonia (CAP) ... IDSA #Outpatient #CAP ... #Community #Acquired ... #Pneumonia #Antibiotics ... Management #Guidelines #pharmacology
Linezolid (Zyvox) (PO and IV) - Antibiotics Class Overview

Mechanism: Oxazolidinone class –unique ribosomal inhibitor (acts on
Class Overview ... titssue infections, HAP ... /HCAP/VAP with suspected ... infections #Pharmacology ... #Antibiotics #Review
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Class Overview ... Severe cryptococcal pneumonia ... #Pharmacology #Antibiotics ... #Review #Overview ... #Flutycosine #Antifungal
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... pneumonia, sinusitis ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics ... #Review #Overview
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Class Overview ... nosocomial infections (HAP ... /VAP, catheter-related ... Polymyxin B(IV) #Pharmacology ... #Antibiotics #Review